The use of 5-aminosalicylate for patients with Crohn’s disease in a prospective European inception cohort with 5 years follow-up – an Epi-IBD study

  1. Burisch, J.
  2. Bergemalm, D.
  3. Halfvarson, J.
  4. Domislovic, V.
  5. Krznaric, Z.
  6. Goldis, A.
  7. Dahlerup, J.F.
  8. Oksanen, P.
  9. Collin, P.
  10. de Castro, L.
  11. Hernandez, V.
  12. Turcan, S.
  13. Belousova, E.
  14. D'Incà, R.
  15. Sartini, A.
  16. Valpiani, D.
  17. Giannotta, M.
  18. Misra, R.
  19. Arebi, N.
  20. Duricova, D.
  21. Bortlik, M.
  22. Gatt, K.
  23. Ellul, P.
  24. Pedersen, N.
  25. Kjeldsen, J.
  26. Andersen, K.W.
  27. Andersen, V.
  28. Katsanos, K.H.
  29. Christodoulou, D.K.
  30. Sebastian, S.
  31. Barros, L.
  32. Magro, F.
  33. Midjord, J.M.M.
  34. Nielsen, K.R.
  35. Salupere, R.
  36. Kievit, H.A.L.
  37. Kiudelis, G.
  38. Kupčinskas, J.
  39. Fumery, M.
  40. Gower-Rousseau, C.
  41. Kaimakliotis, I.P.
  42. Schwartz, D.
  43. Odes, S.
  44. Lakatos, L.
  45. Lakatos, P.L.
  46. Langholz, E.
  47. Munkholm, P.
  48. Show all authors +
Journal:
United European Gastroenterology Journal

ISSN: 2050-6414,  2050-6406

Year of publication: 2020

Volume: 8

Issue: 8

Pages: 949-960

Type: Article

DOI: 10.1177/2050640620945949 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

Data source: Scopus